Skip to content

Development of an online, group-based, clinical neuropsychology rehabilitation programme

Development and refinement of an online, group-based, clinical neuropsychology rehabilitation programme to improve psychological well-being and quality of life after acquired brain injury

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN13391549
Enrollment
12
Registered
2023-09-15
Start date
2023-05-30
Completion date
Unknown
Last updated
2026-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acquired brain injury Nervous System Diseases

Interventions

Baseline assessment All participants at the baseline stage will complete questionnaires online with the study Research Support Fellow. Questionnaires will assess well-being, mood, anxiety, suicide ris

Sponsors

University of Nottingham
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Acquired brain injury experienced as an adult (>18 years), at least 3 months prior to joining the study 2. Age >18 years 3. Self-reported sense of being ‘stuck’ and/or emotional difficulties related to ABI rehabilitation (screened during initial interview) 4. English-speaking 5. Able to access the online platform 6. Ability to give informed consent and complete outcome measures

Exclusion criteria

Exclusion criteria: 1. Pre-existing intellectual disability 2. Severe psychiatric disorder (at time of screening or in previous year), and/or factors (e.g., suicidal intent or ideation) indicating alternative treatment may take priority 3. Comorbid neurodegenerative condition 4. Indication that group intervention may not be appropriate (screened during baseline and initial interview)

Design outcomes

Primary

MeasureTime frame
1. Mood/Depression measured using Patient Health Questionnaire 9 at baseline, and 2-weeks post intervention completion. 2. Risk of suicide using the Columbia Suicide Severity Rating Scale at baseline, and 2-weeks post intervention completion. 3. Anxiety using the Generalised Anxiety Scale-7 at baseline, and 2-weeks post intervention completion. 4. Acceptance using the Acceptance and Action Questionnaire at baseline, and 2-weeks post intervention completion. 5. Living towards values using the Valued Living Questionnaire at baseline, and 2-weeks post intervention completion. 6. Self-compassion using the Self-Compassion questionnaire at baseline, and 2-weeks post intervention completion. 7. Cognition using the ACE-III (mini) at baseline, and 2-weeks post intervention completion. 8. Goal attainment using the GAS-Lite at baseline, and 2-weeks post intervention completion. 9. Quality of life measured using the QOLIBRI at baseline, and 2-weeks post intervention completion (awaiting confirmation from ethics as submitted as an amendment)

Secondary

MeasureTime frame
There are no secondary outcome measures

Countries

England, United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: May 16, 2026